fda glp-1 compounding crackdown news is moving to restrict mass-marketed compounded products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified FDA says that the GLP-1

All such findings derive from laboratory, animal, and clinical-research settings and are reported here strictly as experimental observations

It is often associated with insulin resistance and can lead to weight gain

10.1038/jcbfm.2010.162 J

A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer

Based on the available research, ipamorelin treatment appears to create few adverse effects in test subjects

In general, the longer-acting GLP-1 agonists which are injected weekly, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), are associated with greater weight loss than the shorter-acting GLP-1 agonists such as liraglutide (Saxenda)